Team:Slovenia

From 2012.igem.org

(Difference between revisions)
(→Project description)
Line 1: Line 1:
-
== Switch-IT (Inducible therapeutics) ==
 
-
Currently, biological drug-based therapies require periodic invasive application. Often, due to their systemic administration, adverse effects are observed. Furthermore, large quantities of these substances are needed because of their distribution throughout the body. This, coupled with expensive production and especially purification, imposes a great burden on health systems. We aim to develop a safe and cost-effective biological delivery system for biopharmaceuticals, which would increase the quality of patients' lives, because it would minimize the number of required procedures. This type of delivery system would increase patient compliance to the therapy while the local administration will reduce the side-effects associated with current treatments.  We plan to design the mammalian cells-based delivery system to be regulated by the digital logic from the outside.
 
-
----
 
-
 
-
 
<html>
<html>
<head>
<head>
 +
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
 +
 +
<style type="text/css">
 +
 +
 +
#container {background:#fff; margin:0 auto 0px; padding:5px 0px 0px; width:960px; border-radius:10px;}
 +
#main {background:#fff; width:950px; padding-left:15px; padding-right:15px; padding-top:0px; padding-bottom:10px; margin-top:0px; border-top-left-radius:0px; border-top-right-radius:0px; border-bottom-left-radius:10px; border-bottom-right-radius:10px;  font-family: Arial, "Helvetica Neue", Helvetica, sans-serif; font-size:110%; }
 +
 +
#mainmenu {background:#fff; width:980px; padding-left:0px; padding-right:0px; padding-top:0px; padding-bottom:0px; margin-top:0px; border-top-left-radius:2px; border-top-right-radius:2px; border-bottom-left-radius:10px; border-bottom-right-radius:10px;  font-family: Arial, "Helvetica Neue", Helvetica, sans-serif; font-size:110%; }
 +
 +
 +
 +
p {line-height:1.5em; margin:0 0 15px; text-align:left;}
 +
h2 {font-size:1.8em; font-weight:400; margin:0 0 12px;}
 +
 +
.clearfix:after{clear:both;content:".";display:block;height:0;visibility:hidden;}
 +
* html .clearfix{height:1%;}
 +
*:first-child+html .clearfix{min-height:1%;}
 +
 +
img { display: block; margin-left: auto; margin-right: auto }
 +
 +
a, a:visited, a:active {border-bottom:1px dotted #505050; color:#0C5DA5; text-decoration:none;}
 +
a:hover {border-bottom:1px solid #505050; color:#303030; text-decoration:none;}
 +
a img {border:0;}
 +
 +
.firstHeading {display:none;}
 +
 +
/*#footer-box { display:none ;}*/
 +
#footer-box { width: 950px; border:none; border-radius:10px; padding:15px 15px 15px 15px; margin-bottom:10px;}
 +
 +
#top-section {
 +
    position: relative;
 +
    height: 0px;
 +
    width: 965px;
 +
    margin: 0 auto 0 auto;
 +
    border-left: 1px solid #444444;
 +
    border-right: 1px solid #444444;
 +
border-bottom: 0px;
 +
}
 +
 +
 +
#catlinks { display:none; }
 +
 +
 +
#p-logo { display:none;}
 +
 +
 +
#column-one { padding-top:0px; padding: 0 0 0 0;}
 +
 +
body
 +
{
 +
margin:0;
 +
padding:15px 0 0;
 +
background-color: #ececec;
 +
background-image:url("https://static.igem.org/mediawiki/2012/5/5d/Svn12_bckg_css.png");
 +
background-repeat:repeat;
 +
}
 +
 +
 +
#content{
 +
background-color: transparent;
 +
border-left: none;
 +
border-right: none;
 +
width:980px;
 +
}
 +
 +
#search-controls {
 +
display:none;
 +
}
 +
 +
 +
#banner{
 +
background-image:url("https://static.igem.org/mediawiki/2012/8/84/Svn12_bannerx_temp.png");
 +
background-position: center;
 +
background-repeat: no-repeat;
 +
width:980;
 +
height:239px;
 +
font-family:Arial;
 +
font-size:12px;
 +
padding-left:268px;
 +
}
 +
 +
 +
 +
/* menu (page, edit ...) */
 +
#menubar {
 +
    position: absolute;
 +
    white-space: nowrap;
 +
    top: -6px;
 +
    width: 400px;
 +
    z-index: 5;
 +
    font-family: sans-serif;
 +
    font-size: 95%;
 +
    line-height: 1em;
 +
}
 +
 +
.left-menu, .left-menu a {
 +
    left: 0px;
 +
    text-align: left;
 +
    color:#114472;
 +
    text-transform: lowercase;
 +
}
 +
 +
.left-menu:hover {
 +
    color: #114472;
 +
    background-color: transparent;
 +
}
 +
.right-menu, .right-menu a {
 +
    right: 0px;
 +
    text-align: right;
 +
    color: #114472;
 +
}
 +
#menubar ul {
 +
    color: #114472;
 +
    list-style: none;
 +
}
 +
#menubar li {
 +
    display: inline;
 +
    position: relative;
 +
    cursor: pointer;
 +
    padding-left: 0px;
 +
    padding-right: 0px;
 +
}
 +
.left-menu li a {
 +
    padding: 0px 10px 0px 0px;
 +
}
 +
.left-menu .selected {
 +
#    color: #114472;
 +
}
 +
#.left-menu .selected:hover {
 +
#    color: #114472;
 +
#}
 +
 +
.left-menu:hover a {
 +
    color: #114472;;
 +
}
 +
.right-menu li {
 +
#    background-color: transparent;
 +
}
 +
.right-menu li a {
 +
    padding: 0px 15px 0px 0px;
 +
    color: #114472;;
 +
    background-color: transparent;
 +
}
 +
.right-menu li a:hover {
 +
    color: #114472;
 +
    text-decoration: underline;
 +
}
 +
/* end menu (edit, page ...) */
 +
 +
 +
/* Tables */
 +
/* IE 6: http://webdesign.about.com/od/tables/qt/tiptablecenter.htm */
 +
table.normal { border-collapse: collapse; margin: auto; width:70%; margin-bottom:15px; }
 +
td.normal, th.normal { padding-left: 1.4em; padding-right: 1.4em; padding-top: 0.4em; padding-bottom: 0.4em; border: 1px #d8d8d8 solid; }
 +
thead.normal{ background: #0C5DA5; color:#ffffff; border: 1px #d8d8d8 solid; }
 +
tbody .normal{ background: #fff; }
 +
 +
 +
/* invisible table */
 +
table.invisible{ border-collapse: collapse; margin: auto; width:100%; margin-bottom:15px; }
 +
td.invisible, th.invisible { padding-left: 1.4em; padding-right: 1.4em; padding-top: 0.4em; padding-bottom: 0.4em; border:none; }
 +
thead.invisible{ background: #0C5DA5; color:#ffffff; border:none; }
 +
tbody .invisible{ background: #fff; }
 +
 +
 +
/* summary table */
 +
table.summary{ border-collapse: collapse; margin: auto; width:100%; margin-bottom:10px; }
 +
td.summary, th.summary{ background:#d0ecf4; color:#000000; padding-left: 5px; padding-right: 15px; padding-top: 15px; padding-bottom: 15px; border:none; border-radius:0px;}
 +
thead.summary{ background:#d0ecf4; color:#000000; border:none; border-radius:0px; }
 +
tbody.summary{ background: #fff; }
 +
 +
 +
 +
/* CSS navigation menu (blue) */
 +
#cssmenu{ height:37px; display:block; padding:0; margin:0;  border:1px solid; border-radius:0px; }
 +
#cssmenu > ul {list-style:inside none; padding:0; margin:0;}
 +
#cssmenu > ul > li {list-style:inside none; padding:0; margin:0; float:left; display:block; position:relative;}
 +
#cssmenu > ul > li > a{ outline:none; display:block; position:relative; padding:12px 17px; font:bold 13px/100% Arial, Helvetica, sans-serif; text-align:center; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.4); }
 +
#cssmenu > ul > li:first-child > a{border-radius:5px 0 0 5px;}
 +
#cssmenu > ul > li > a:after{ content:''; position:absolute; border-right:1px solid; top:-1px; bottom:-1px; right:-2px; z-index:99; }
 +
#cssmenu ul li.has-sub:hover > a:after{top:0; bottom:0;}
 +
#cssmenu > ul > li.has-sub > a:before{ content:''; position:absolute; top:18px; right:6px; border:5px solid transparent; border-top:5px solid #fff; }
 +
#cssmenu > ul > li.has-sub:hover > a:before{top:19px;}
 +
#cssmenu ul li.has-sub:hover > a{ background:#043A6B; border-color:#3f3f3f; padding-bottom:13px; padding-top:13px; top:-1px; z-index:999; }
 +
#cssmenu ul li.has-sub:hover > ul, #cssmenu ul li.has-sub:hover > div{display:block;}
 +
#cssmenu ul li.has-sub > a:hover{background:#043A6B; border-color:#3f3f3f;}
 +
#cssmenu ul li > ul, #cssmenu ul li > div{ display:none; width:auto; position:absolute; top:38px; padding:10px 0; background:#043A6B; border-radius:0 5px 5px 5px; z-index:999; }
 +
/*#cssmenu ul li > ul{width:200px;} */
 +
#cssmenu ul li > ul{width:165px;}
 +
#cssmenu ul li > ul li{display:block; list-style:inside none; padding:0; margin:0; position:relative;}
 +
#cssmenu ul li > ul li a{ outline:none; display:block; position:relative; margin:0; padding:8px 20px; font:10pt Arial, Helvetica, sans-serif; color:#fff; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.5); }
 +
#cssmenu, #cssmenu > ul > li > ul > li a:hover
 +
{ background:#043A6B;
 +
background:-moz-linear-gradient(top, #043A6B 0%, #0C5DA5 100%);
 +
background:-webkit-gradient(linear, left top, left bottom, color-stop(0%,#043A6B), color-stop(100%,#0C5DA5));
 +
background:-webkit-linear-gradient(top, #043A6B 0%,#0C5DA5 100%);
 +
background:-o-linear-gradient(top,  #043A6B 0%,#0C5DA5 100%);
 +
background:-ms-linear-gradient(top, #043A6B 0%,#0C5DA5 100%);
 +
background:linear-gradient(top,  #043A6B 0%,#0C5DA5 100%);
 +
filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#043A6B', endColorstr='#0C5DA5',GradientType=0);
 +
}
 +
#cssmenu{border-color:#043A6B;}
 +
#cssmenu > ul > li > a{border-right:1px solid #043A6B; color:#fff;}
 +
#cssmenu > ul > li > a:after{border-color:#0C5DA5;}
 +
#cssmenu > ul > li > a:hover{background:#0C5DA5;}
 +
/* end CSS navigation menu (blue) */
 +
 +
 +
ul {
 +
    line-height: 1.5em;
 +
    list-style-type: square;
 +
    margin: 0 0 0 0;
 +
    padding: 0;
 +
    /*list-style-image: url(bullet.gif);*/
 +
}
 +
 +
.abstract {background:#0C5DA5; color:#ffffff; padding:10px; border-radius:5px;}
 +
 +
</style>
 +
 +
Line 25: Line 242:
</head>
</head>
-
</html>
+
<body>
 +
<div id="banner">
 +
</div>
-
<html>
 
 +
<!--<div id="container">-->
 +
<div id="mainmenu">
-
<!-- MathJax (LaTeX for the web) -->
+
<!-- start main menu -->
-
<!-- This part is only if you want to use $...$ delimiters -->
+
-
<script type="text/x-mathjax-config">
+
-
    MathJax.Hub.Config({tex2jax: {inlineMath: [['$','$'], ['\\(','\\)']]}});
+
-
</script>
+
-
<script type="text/javascript" src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
+
 +
<div id='cssmenu'>
 +
<ul>
 +
<li><a href='https://2012.igem.org/Team:Slovenia'><span>Home</span></a></li>
 +
<li><a href='https://2012.igem.org/Team:Slovenia/Safety'><span>Safety</span></a></li>
 +
</div>
-
<!-- Sample LaTeX >
+
<!-- end main menu -->
-
$x = x_2$ <br />
+
</div> <!-- end menu -->
-
Sample text. <br />
+
-
$X = \frac{\alpha}{b}$ <br />
+
-
$\frac{dx}{dt} = \frac{K^n}{1 + K^n}$
+
-
<-->
+
-
</html>
+
<div id="main">
 +
<br/>
 +
<h2>Switch-IT :: Inducible Therapeutics</h2>
 +
Currently, biological drug-based therapies require periodic invasive application. Often, due to their systemic administration, adverse effects are observed. Furthermore, large quantities of these substances are needed because of their distribution throughout the body. This, coupled with expensive production and especially purification, imposes a great burden on health systems. We aim to develop a safe and cost-effective biological delivery system for biopharmaceuticals, which would increase the quality of patients' lives, because it would minimize the number of required procedures. This type of delivery system would increase patient compliance to the therapy while the local administration will reduce the side-effects associated with current treatments.  We plan to design the mammalian cells-based delivery system to be regulated by the digital logic from the outside.
 +
<br/>
 +
<br/>
 +
</div>
 +
<!--</div>-->
 +
</body>
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
</html>
-
!align="center"|[[Team:Slovenia|Home]]
+
-
!align="center"|[[Team:Slovenia/Team|Team]]
+
-
!align="center"|[https://igem.org/Team.cgi?year=2012&team_name=Slovenia Official Team Profile]
+
-
!align="center"|[[Team:Slovenia/Project|Project]]
+
-
!align="center"|[[Team:Slovenia/Parts|Parts Submitted to the Registry]]
+
-
!align="center"|[[Team:Slovenia/Modeling|Modeling]]
+
-
!align="center"|[[Team:Slovenia/Notebook|Notebook]]
+
-
!align="center"|[[Team:Slovenia/Safety|Safety]]
+
-
!align="center"|[[Team:Slovenia/Attributions|Attributions]]
+
-
|}
+

Revision as of 00:19, 20 September 2012


Switch-IT :: Inducible Therapeutics

Currently, biological drug-based therapies require periodic invasive application. Often, due to their systemic administration, adverse effects are observed. Furthermore, large quantities of these substances are needed because of their distribution throughout the body. This, coupled with expensive production and especially purification, imposes a great burden on health systems. We aim to develop a safe and cost-effective biological delivery system for biopharmaceuticals, which would increase the quality of patients' lives, because it would minimize the number of required procedures. This type of delivery system would increase patient compliance to the therapy while the local administration will reduce the side-effects associated with current treatments. We plan to design the mammalian cells-based delivery system to be regulated by the digital logic from the outside.

Retrieved from "http://2012.igem.org/Team:Slovenia"